Mindy Lee-Olsen, 408-731-5523 (Media)Vice President, Marketing ServicesorDoug Farrell, 408-731-5285 (Investors)Vice President, Investor Relations (NASDAQ:AFFX) announced today the availability of ...
Affymetrix said today it will collaborate with XRGenomics to develop next-generation diagnostic tests for age-related diseases. The alliance builds on an existing partnership between the companies, as ...
Affymetrix and Cytox have agreed to collaborate on developing and commercializing a blood-based genetic assay for research in diagnosis and prognosis of Alzheimer’s disease (AD) and mild cognitive ...
SANTA CLARA, Calif. and WASHINGTON, June 3 -- Affymetrix, Inc. (Nasdaq: AFFX) and the American Association for the Advancement of Science (AAAS) today announced Affymetrix' support of the AAAS Newcomb ...
In the wake of Thermo Fisher Scientific, Inc.'s TMO impending acquisition of Affymetrix, Inc. AFFX, the latter has finally chosen to stick to Thermo Fisher's $1.3 billion takeover bid. With this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results